Groupama Asset Managment Raises Holdings in Cardinal Health, Inc. $CAH

Groupama Asset Managment lifted its stake in Cardinal Health, Inc. (NYSE:CAH) by 7.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,304 shares of the company’s stock after buying an additional 877 shares during the quarter. Groupama Asset Managment’s holdings in Cardinal Health were worth $1,679,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health during the first quarter worth approximately $26,000. Bellwether Advisors LLC purchased a new position in Cardinal Health during the fourth quarter worth approximately $32,000. Tompkins Financial Corp boosted its position in Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company’s stock worth $34,000 after purchasing an additional 128 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new position in Cardinal Health during the fourth quarter worth approximately $36,000. Finally, GW&K Investment Management LLC boosted its position in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Transactions at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 235,775 shares of company stock valued at $35,102,939. 0.09% of the stock is currently owned by company insiders.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $152.6480 on Thursday. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44. The stock has a market capitalization of $36.45 billion, a P/E ratio of 23.67, a PEG ratio of 1.26 and a beta of 0.67. The business has a 50 day simple moving average of $159.46 and a two-hundred day simple moving average of $144.99.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same quarter last year, the firm earned $1.84 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Analysts Set New Price Targets

CAH has been the topic of a number of recent analyst reports. Bank of America increased their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday, June 10th. Citigroup reiterated a “neutral” rating and set a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $163.20.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.